Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Simon Pacouret"'
Autor:
Fatma-Elzahraa Eid, Albert T. Chen, Ken Y. Chan, Qin Huang, Qingxia Zheng, Isabelle G. Tobey, Simon Pacouret, Pamela P. Brauer, Casey Keyes, Megan Powell, Jencilin Johnston, Binhui Zhao, Kasper Lage, Alice F. Tarantal, Yujia A. Chan, Benjamin E. Deverman
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-14 (2024)
Abstract Broadening gene therapy applications requires manufacturable vectors that efficiently transduce target cells in humans and preclinical models. Conventional selections of adeno-associated virus (AAV) capsid libraries are inefficient at search
Externí odkaz:
https://doaj.org/article/63fea91c4ddf435fb80d6986bfc4dbae
Autor:
Magalie Penaud-Budloo, Emilie Lecomte, Quentin Lecomte, Simon Pacouret, Frédéric Broucque, Aurélien Guy-Duché, Jean-Baptiste Dupont, Laurence Jeanson-Leh, Cécile Robin, Véronique Blouin, Eduard Ayuso, Oumeya Adjali
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 32, Iss 3, Pp 101305- (2024)
With more than 130 clinical trials and 8 approved gene therapy products, adeno-associated virus (AAV) stands as one of the most popular vehicles to deliver therapeutic DNA in vivo. One critical quality attribute analyzed in AAV batches is the presenc
Externí odkaz:
https://doaj.org/article/042640a504cc42909af1d623d410fa67
Autor:
Michael Florea, Fotini Nicolaou, Simon Pacouret, Eric M. Zinn, Julio Sanmiguel, Eva Andres-Mateos, Carmen Unzu, Amy J. Wagers, Luk H. Vandenberghe
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 28, Iss , Pp 146-159 (2023)
The adeno-associated viral vector (AAV) provides a safe and efficient gene therapy platform with several approved products that have marked therapeutic impact for patients. However, a major bottleneck in the development and commercialization of AAV r
Externí odkaz:
https://doaj.org/article/b21e4b6154cf46b4a7fae892eb16cad8
Autor:
Pauline F. Schmit, Simon Pacouret, Eric Zinn, Elizabeth Telford, Fotini Nicolaou, Frédéric Broucque, Eva Andres-Mateos, Ru Xiao, Magalie Penaud-Budloo, Mohammed Bouzelha, Nicolas Jaulin, Oumeya Adjali, Eduard Ayuso, Luk H. Vandenberghe
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 107-121 (2020)
Generation and screening of libraries of adeno-associated virus (AAV) variants have emerged as a powerful method for identifying novel capsids for gene therapy applications. For the majority of libraries, vast population diversity requires multiplexe
Externí odkaz:
https://doaj.org/article/01e94c81cf474557ad14df40eac9da49
Autor:
Anna C. Maurer, Simon Pacouret, Ana Karla Cepeda Diaz, Jessica Blake, Eva Andres-Mateos, Luk H. Vandenberghe
Publikováno v:
Cell Reports, Vol 23, Iss 6, Pp 1817-1830 (2018)
Summary: The adeno-associated virus (AAV) vector is a preferred delivery platform for in vivo gene therapy. Natural and engineered variations of the AAV capsid affect a plurality of phenotypes relevant to gene therapy, including vector production and
Externí odkaz:
https://doaj.org/article/d96a300cf0694e8cad6fb2c4ad63a814
Autor:
Eric Zinn, Simon Pacouret, Vadim Khaychuk, Heikki T. Turunen, Livia S. Carvalho, Eva Andres-Mateos, Samiksha Shah, Rajani Shelke, Anna C. Maurer, Eva Plovie, Ru Xiao, Luk H. Vandenberghe
Publikováno v:
Cell Reports, Vol 12, Iss 6, Pp 1056-1068 (2015)
Adeno-associated virus (AAV) vectors have emerged as a gene-delivery platform with demonstrated safety and efficacy in a handful of clinical trials for monogenic disorders. However, limitations of the current generation vectors often prevent broader
Externí odkaz:
https://doaj.org/article/9941e6a1cc964651b74a08eb30bc49f9
Autor:
Trevor Krolak, Ken Y. Chan, Luke Kaplan, Qin Huang, Jason Wu, Qingxia Zheng, Velina Kozareva, Thomas Beddow, Isabelle G. Tobey, Simon Pacouret, Albert T. Chen, Yujia A. Chan, Daniel Ryvkin, Chenghua Gu, Benjamin E. Deverman
Publikováno v:
Nature Cardiovascular Research. 1:389-400
Endothelial cells have a crucial role in nervous system function, and mounting evidence points to endothelial impairment as a major contributor to a wide range of neurological diseases. However, tools to genetically interrogate these cells
Autor:
Fatma-Elzahraa Eid, Albert T. Chen, Ken Y. Chan, Qin Huang, Qingxia Zheng, Isabelle G. Tobey, Simon Pacouret, Pamela P. Brauer, Casey Keyes, Megan Powell, Jencilin Johnston, Binhui Zhao, Kasper Lage, Alice F. Tarantal, Yujia A. Chan, Benjamin E. Deverman
Broadening gene therapy applications requires manufacturable vectors that efficiently transduce target cells in humans and preclinical models. Conventional selections of adeno-associated virus (AAV) capsid libraries are inefficient at searching the v
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c36b36c2803d784598b9e858674bfeae
https://doi.org/10.1101/2022.12.22.521680
https://doi.org/10.1101/2022.12.22.521680
Autor:
Mirja Hommel, Dimitri Alvarez-Dorta, Oumeya Adjali, Aurélien Leray, Eduard Ayuso, Gloria González-Aseguinolaza, Simon Pacouret, Mickaël Guilbaud, Mohammed Bouzelha, Philippe Moullier, Sébastien G. Gouin, Laurence Dubreil, Mathieu Mével, Véronique Blouin, Jean Philippe Combal, David Deniaud, Magalie Penaud-Budloo
Publikováno v:
Chemical Science
Chemical Science, The Royal Society of Chemistry, 2020, 11 (4), pp.1122-1131. ⟨10.1039/C9SC04189C⟩
Chemical Science, 2020, 11 (4), pp.1122-1131. ⟨10.1039/C9SC04189C⟩
Chemical Science, The Royal Society of Chemistry, 2020, 11 (4), pp.1122-1131. ⟨10.1039/C9SC04189C⟩
Chemical Science, 2020, 11 (4), pp.1122-1131. ⟨10.1039/C9SC04189C⟩
Gene delivery vectors based on adeno-associated virus (AAV) are highly promising due to several desirable features of this parent virus, including a lack of pathogenicity, efficient infection of dividing and non-dividing cells and sustained maintenan
Autor:
Laurence Lim, Luk H. Vandenberghe, Eric Zinn, Sarah Wassmer, Aliete Langsdorf, Jason Comander, Samiksha Shah, Livia S. Carvalho, Leo A. Kim, Ru Xiao, Simon Pacouret
Publikováno v:
Human Gene Therapy. 29:771-784
Gene therapy is a promising approach in the treatment of inherited and common complex disorders of the retina. Preclinical and clinical studies have validated the use of adeno-associated viral vectors (AAV) as a safe and efficient delivery vehicle fo